An NIHR-funded evaluation of specialist hospital discharge services for homeless patients confirmed that they helped prevent discharge to the street, reduced emergency readmissions and were cost-effective for the NHS.
The NIHR Global Health Research Group in Surgical Technologies has developed and trained surgeons to use innovative new devices, enabling routine surgery in remote communities in low-resource settings.
The NIHR Health Protection Research Unit in Modelling and Health Economics played a critical role in providing urgent public health advice to policy makers during the Covid-19 pandemic. Their research contributed to saving tens of thousands of lives in the UK and internationally.
Vocational advice in primary care supports a faster return to work for patients with musculoskeletal pain
Gwenllian Wynne-Jones used NIHR funding to develop vocational advice that significantly reduced work absence among patients with musculoskeletal disorders.
An NIHR-funded feasibility study about life story work with people with dementia showed how the approach could help people connect.
Combining computer-based speech and language therapy with usual NHS care can help some people improve their communication following a stroke.
Researchers from three NIHR Health Protection Research Units have found that flooding can have a significant negative impact on the mental health of people whose homes are flooded, as well as those whose lives are disrupted by flooding events. Their research has informed guidance for local authorities, policy makers and public health practitioners on planning for and dealing with the aftermath of a flood.
Innovative research into the provision of communication aids for non-speaking children has created new guidance to improve the way aid is provided.
A simple technique in which patients hold their breath for up to 20 seconds to spare the heart from radiotherapy during breast cancer treatment has been adopted as the standard of care across many UK hospitals.
Evidence from a gene therapy trial has contributed to a partnership between researchers and commercial companies to develop clinical trials and a potential treatment for cystic fibrosis